Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) Stock Rated “Buy” by Sell-Side Analysts

Shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) have been given a consensus rating of “Buy” by the five brokerages that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have issued a buy rating and two have assigned a strong buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $16.00.

Several analysts have issued reports on LMRI shares. Barclays upped their price objective on Lumexa Imaging from $9.00 to $13.00 and gave the company an “overweight” rating in a research note on Friday, August 28th. Wall Street Zen upgraded shares of Lumexa Imaging from a “hold” rating to a “buy” rating in a report on Saturday. KeyCorp assumed coverage on Lumexa Imaging in a report on Thursday, September 24th. They issued an “overweight” rating and a $18.00 target price on the stock. UBS Group restated a “strong-buy” rating on shares of Lumexa Imaging in a research note on Monday. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Lumexa Imaging in a report on Tuesday, September 22nd.

Hedge Funds Weigh In On Lumexa Imaging

A number of hedge funds have recently modified their holdings of LMRI. Bank of America Corp DE increased its holdings in shares of Lumexa Imaging by 1,855,116.7% in the 1st quarter. Bank of America Corp DE now owns 111,313 shares of the company’s stock worth $957,000 after purchasing an additional 111,307 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Lumexa Imaging during the first quarter valued at $778,000. BlackRock Inc. purchased a new stake in shares of Lumexa Imaging during the second quarter valued at $15,771,000. Brigade Capital Management LP bought a new stake in Lumexa Imaging in the 2nd quarter worth about $7,511,000. Finally, Janus Henderson Group PLC raised its position in Lumexa Imaging by 5.4% in the 1st quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock worth $18,063,000 after buying an additional 107,903 shares during the last quarter.

Lumexa Imaging Price Performance

NASDAQ:LMRI opened at $10.32 on Monday. The business’s 50-day moving average price is $11.30 and its 200 day moving average price is $10.30. The firm has a market cap of $991.44 million and a P/E ratio of -21.06. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 1.40. Lumexa Imaging has a 52-week low of $6.45 and a 52-week high of $19.45.

Lumexa Imaging (NASDAQ:LMRI) last announced its earnings results on Wednesday, August 12th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.17. The firm had revenue of $264.16 million for the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. As a group, sell-side analysts predict that Lumexa Imaging will post 0.25 earnings per share for the current fiscal year.

Lumexa Imaging Company Profile

Lumexa Imaging, Inc (NASDAQ: LMRI) is a U.S. healthcare services company focused on outpatient diagnostic imaging. The company operates and supports imaging centers that provide noninvasive services used to detect, diagnose and monitor medical conditions.

Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound, X-ray and other diagnostic imaging procedures. Lumexa also works with radiologists and referring healthcare providers to deliver image interpretation and related clinical services.

The company’s operations are primarily located in the United States, serving patients through a network of outpatient imaging facilities and affiliated radiology practices.